Pages that link to "Q81826825"
Jump to navigation
Jump to search
The following pages link to Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular risk (Q81826825):
Displaying 9 items.
- Oxidative stress in patients with obstructive sleep apnoea syndrome (Q26768589) (← links)
- Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives (Q34697950) (← links)
- Reactive oxygen species and the brain in sleep apnea (Q34939523) (← links)
- Oxidative stress and quality of life in elderly patients with obstructive sleep apnea syndrome: are there differences after six months of Continuous Positive Airway Pressure treatment? (Q36017234) (← links)
- Obstructive sleep apnea and bone mineral density in obese patients (Q36393873) (← links)
- Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome (Q36537445) (← links)
- Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome (Q37015491) (← links)
- Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment. (Q37495691) (← links)
- Changes of aldosterone levels in patients with type 2 diabetes complicated by moderate to severe obstructive sleep apnea-hypopnea syndrome before and after treatment with continuous positive airway pressure (Q92851992) (← links)